Heart Failure

IPAC:  Immune activation and myocardial recovery in peripartum cardiomyopathy assessment of left ventricular ejection fraction by echo and blood sampling for women diagnosed with peripartum cmo within 2 months after delivery.

Evaluation of Multisensor Data in Heart Failure Patients With Implanted Devices (MultiSENSE)

The goal of the MultiSENSE study is to collect chronic information from multiple sensors in an implanted device for evaluation in heart failure patients. 

Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy (LAPTOP-HF)

The purpose of this clinical study is to evaluate the safety and clinical effectiveness of use of a physician-directed, patient self-management system, guided by left atrial pressure measurements, for use in patients with heart failure. The system allows patients to adjust their HF medications daily based on a physician-directed prescription plan and their current HF status, similar to the manner in which diabetes patients manage their insulin therapy. The goal of the LAPTOP-HF study is to demonstrate reductions in episodes of worsening heart failure (HF) and hospitalizations in patients who are managed with the left atrial pressure (LAP) management system (treatment group) versus those who receive only the current standard of care (control group).
 

Note: For additional information on any trial please contact the Nurse Coordinator as listed above.